142 related articles for article (PubMed ID: 2275237)
1. Fluosol: an oxygen-delivery fluid for use in percutaneous transluminal coronary angioplasty.
Garrelts JC
DICP; 1990 Nov; 24(11):1105-12. PubMed ID: 2275237
[TBL] [Abstract][Full Text] [Related]
2. Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol.
Kent KM; Cleman MW; Cowley MJ; Forman MB; Jaffe CC; Kaplan M; King SB; Krucoff MW; Lassar T; McAuley B
Am J Cardiol; 1990 Aug; 66(3):279-84. PubMed ID: 2195864
[TBL] [Abstract][Full Text] [Related]
3. Prevention of ischemia during percutaneous transluminal coronary angioplasty by transcatheter infusion of oxygenated Fluosol DA 20%.
Cleman M; Jaffee CC; Wohlgelernter D
Circulation; 1986 Sep; 74(3):555-62. PubMed ID: 2943533
[TBL] [Abstract][Full Text] [Related]
4. Dissociation of ST segment elevation and regional wall motion with open-artery, intracoronary Fluosol.
Schaer GL; Krucoff MW; Green C; Visner MS
Am Heart J; 1989 Oct; 118(4):679-85. PubMed ID: 2529747
[TBL] [Abstract][Full Text] [Related]
5. Protection against ischemia during prolonged balloon inflation by distal coronary perfusion with use of an autoperfusion catheter or Fluosol.
Robalino BD; Marwick T; Lafont A; Vaska K; Whitlow PL
J Am Coll Cardiol; 1992 Nov; 20(6):1378-84. PubMed ID: 1430688
[TBL] [Abstract][Full Text] [Related]
6. Does intracoronary infusion of Fluosol-DA 20% prevent left ventricular diastolic dysfunction during coronary balloon angioplasty?
Bell MR; Nishimura RA; Holmes DR; Bailey KR; Schwartz RS; Vlietstra RE
J Am Coll Cardiol; 1990 Oct; 16(4):959-66. PubMed ID: 2212378
[TBL] [Abstract][Full Text] [Related]
7. Intravenous Fluosol in the treatment of acute myocardial infarction. Results of the Thrombolysis and Angioplasty in Myocardial Infarction 9 Trial. TAMI 9 Research Group.
Wall TC; Califf RM; Blankenship J; Talley JD; Tannenbaum M; Schwaiger M; Gacioch G; Cohen MD; Sanz M; Leimberger JD
Circulation; 1994 Jul; 90(1):114-20. PubMed ID: 8025985
[TBL] [Abstract][Full Text] [Related]
8. Perfluorochemical perfusion during coronary angioplasty in unstable and high-risk patients.
Cowley MJ; Snow FR; DiSciascio G; Kelly K; Guard C; Nixon JV
Circulation; 1990 Mar; 81(3 Suppl):IV27-34. PubMed ID: 2306847
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular applications of fluorocarbons: current status and future direction--a critical clinical appraisal.
Ogilby JD
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1083-96. PubMed ID: 7849911
[TBL] [Abstract][Full Text] [Related]
10. Effects of intracoronary infusion of arterial blood or Fluosol-DA 20% on regional myocardial metabolism and function during brief coronary artery occlusions.
Tokioka H; Miyazaki A; Fung P; Rajagopalan RE; Kar S; Meerbaum S; Corday E; Drury JK
Circulation; 1987 Feb; 75(2):473-81. PubMed ID: 2948736
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of myocardial reperfusion injury in humans: results of a pilot study utilizing acute coronary angioplasty with perfluorochemical in anterior myocardial infarction.
Forman MB; Perry JM; Wilson BH; Verani MS; Kaplan PR; Shawl FA; Friesinger GC
J Am Coll Cardiol; 1991 Oct; 18(4):911-8. PubMed ID: 1894864
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic perturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion.
Forman MB; Pitarys CJ; Vildibill HD; Lambert TL; Ingram DA; Virmani R; Murray JJ
J Am Coll Cardiol; 1992 Jan; 19(1):205-16. PubMed ID: 1729335
[TBL] [Abstract][Full Text] [Related]
13. Preservation of left ventricular ejection fraction during percutaneous transluminal coronary angioplasty by distal transcatheter coronary perfusion of oxygenated Fluosol DA 20%.
Jaffe CC; Wohlgelernter D; Cabin H; Bowman L; Deckelbaum L; Remetz M; Cleman M
Am Heart J; 1988 Jun; 115(6):1156-64. PubMed ID: 2967624
[TBL] [Abstract][Full Text] [Related]
14. Role of perfluorochemical emulsions in the treatment of myocardial reperfusion injury.
Forman MB; Ingram DA; Murray JJ
Am Heart J; 1992 Nov; 124(5):1347-57. PubMed ID: 1442506
[TBL] [Abstract][Full Text] [Related]
15. Effect of adjunctive intracoronary adenosine on myocardial ischemia, hemodynamic function and left ventricular performance during percutaneous transluminal coronary angioplasty: clinical access to ischemic preconditioning?
Heidland UE; Heintzen MP; Michel CJ; Strauer BE
Coron Artery Dis; 2000 Jul; 11(5):421-8. PubMed ID: 10895409
[TBL] [Abstract][Full Text] [Related]
16. A perfluorochemical emulsion as an oxygen carrier.
Yokoyama K; Suyama T; Okamoto H; Watanabe M; Ohyanagi H; Saitoh Y
Artif Organs; 1984 Feb; 8(1):34-40. PubMed ID: 6703924
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic and oxygen transport effects of a perfluorochemical blood substitute, fluosol-DA (20%).
Tremper KK; Lapin R; Levine E; Friedman A; Shoemaker WC
Crit Care Med; 1980 Dec; 8(12):738-41. PubMed ID: 7449405
[TBL] [Abstract][Full Text] [Related]
18. Limitation of myocardial reperfusion injury by intravenous perfluorochemicals. Role of neutrophil activation.
Bajaj AK; Cobb MA; Virmani R; Gay JC; Light RT; Forman MB
Circulation; 1989 Mar; 79(3):645-56. PubMed ID: 2537160
[TBL] [Abstract][Full Text] [Related]
19. Metabolic and functional effects of perfluorocarbon distal perfusion during coronary angioplasty.
Young LH; Jaffe CC; Revkin JH; McNulty PH; Cleman M
Am J Cardiol; 1990 Apr; 65(15):986-90. PubMed ID: 2327360
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary complications after Fluosol administration to patients with life-threatening blood loss.
Police AM; Waxman K; Tominaga G
Crit Care Med; 1985 Feb; 13(2):96-8. PubMed ID: 3967511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
